# CrossBridge Bio, Inc. — Form D

CrossBridge Bio, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-04. The offering totals $17.0M, of which $10.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-11-04
- Form: D
- Accession: 0002043521-24-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $17.0M
- Amount sold: $10.8M
- Remaining: $6.2M
- Investors: 23
- Date of first sale: 2024-10-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-528610

## Issuer

- Name: CrossBridge Bio, Inc.
- CIK: 0002043521
- Entity type: Corporation
- Jurisdiction: UNITED STATES
- Incorporated: 2023
- Address: 2450 HOLCOMBE BLVD, SUITE X, HOUSTON, TX, 77021
- Phone: (346) 547-5202

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| Patrick James Crutcher | Director | Houston, TX |
| Damir F Illich | Director | Houston, TX |
| William F McKeon | Director | Houston, TX |
| Michael Torres | Director | Doral, FL |
| Kyoji Tsuchikama | Director | Houston, TX |
| Michael Torres | Executive Officer | Doral, FL |
| Kyoji Tsuchikama | Executive Officer | Houston, TX |
| Zhiqiang F An | Promoter | Houston, TX |
| Michael Torres | Promoter | Doral, FL |
| Kyoji Tsuchikama | Promoter | Houston, TX |

## More

- [CIK 2043521 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2043521&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002043521-24-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.